ARS Pharmaceuticals Inc
NASDAQ:SPRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ARS Pharmaceuticals Inc
NASDAQ:SPRY
|
US |
|
S
|
SugarBud Craft Growers Corp
F:REL
|
CA |
|
E
|
EBOS Group Ltd
ASX:EBO
|
NZ |
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
Novonix Ltd
F:GC30
|
AU |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
Fomento de Construcciones y Contratas SA
F:FCC
|
ES |
Intrinsic Value
The intrinsic value for
ARS Pharmaceuticals Inc (SPRY) under the Base Case is hidden
USD.
Compared with the current market price of 6 USD, the stock appears hidden
.
SPRY looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if SPRY is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for ARS Pharmaceuticals Inc.
The intrinsic value for
ARS Pharmaceuticals Inc (SPRY) under the Base Case is hidden USD.
Compared with the current market price of 6 USD, the stock appears hidden.